Medicare Enrolled

Dr. David Wenzke, MD

Gastroenterology · Fairfield, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
2990 MACK RD STE 107, Fairfield, OH 45014
5138604801
In practice since 2006 (20 years)
NPI: 1275573354 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wenzke from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wenzke? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wenzke

Dr. David Wenzke is a gastroenterology specialist in Fairfield, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wenzke performed 550 Medicare services across 507 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wenzke received a total of $161,300 from 37 pharmaceutical and/or device companies across 659 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wenzke is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 41% volume in OH $161,300 industry payments

Medicare Practice Summary

Medicare Utilization ↗
550
Medicare services
Top 41% in OH for gastroenterology
507
Unique beneficiaries
$116
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~28 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
121 $200 $1,368
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
83 $71 $1,158
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
59 $63 $233
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
55 $98 $439
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
54 $61 $225
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
36 $99 $1,414
Colonoscopy for colorectal cancer screening, high risk
A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease.
29 $176 $1,108
Colonoscopy
A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon.
28 $132 $1,354
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
26 $122 $512
Upper endoscopy (EGD)
A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope.
19 $81 $957
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
18 $91 $339
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
11 $77 $327
Colonoscopy for colorectal cancer screening
A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease.
11 $176 $1,116
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$161,300
Total received (2018-2024)
Avg $23,043/year across 7 years
Top 3% in OH for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
659
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$154,448 (95.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,327 (3.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$525 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$88,276
2023
$40,469
2022
$10,121
2021
$1,385
2020
$862
2019
$518
2018
$19,670

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$53,052
ABBVIE INC.
$18,386
Phathom Pharmaceuticals, Inc.
$9,187
Lilly USA, LLC
$6,723
Takeda Pharmaceuticals U.S.A., Inc.
$303
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$133
GENZYME CORPORATION
$73
Ipsen Biopharmaceuticals, Inc
$69
Organon Llc
$60
Gilead Sciences, Inc.
$55
IRONWOOD PHARMACEUTICALS, INC
$54
Madrigal Pharmaceuticals
$51
Celgene Corporation
$50
QOL Medical, LLC
$44
Ardelyx, Inc.
$19
Celltrion USA Inc.
$17
Top 3 companies account for 91.3% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$86,425
ABBVIE INC.
$19,453
Takeda Pharmaceuticals U.S.A., Inc.
$11,369
Phathom Pharmaceuticals, Inc.
$9,187
AbbVie, Inc.
$8,734
Janssen Scientific Affairs, LLC
$8,589
AbbVie Inc.
$7,712
Lilly USA, LLC
$6,723
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$511
FUJIFILM Medical Systems USA, Inc.
$412
Gilead Sciences, Inc.
$342
Celgene Corporation
$336
PFIZER INC.
$325
QOL Medical, LLC
$236
Ironwood Pharmaceuticals, Inc
$136
GENZYME CORPORATION
$110
Regeneron Healthcare Solutions, Inc.
$97
IRONWOOD PHARMACEUTICALS, INC
$83
Ipsen Biopharmaceuticals, Inc
$69
Merck Sharp & Dohme LLC
$62
Organon Llc
$60
Madrigal Pharmaceuticals
$51
Merck Sharp & Dohme Corporation
$34
Fresenius Kabi USA, LLC
$28
Braintree Laboratories, Inc.
$26
Organon LLC
$20
Ardelyx, Inc.
$19
Shionogi Inc
$18
Celltrion USA Inc.
$17
Mallinckrodt Hospital Products Inc.
$17
Ferring Pharmaceuticals Inc.
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Olympus America Inc.
$14
INTERCEPT PHARMACEUTICALS, INC.
$13
Intercept Pharmaceuticals, Inc.
$13
EVOKE PHARMA, INC.
$13
Lucid Diagnostics Inc.
$12
Top 3 companies account for 72.7% of all-time payments
Associated products mentioned in payments ›
APRISO · Bylvay · CLENPIQ · CREON · CYLTEZO · DIFICID · DUPIXENT · ENTYVIO · EOHILIA · ESD - Core Endoscopy · EVIS EXERA III VIDEO SYSTEM CENTER · Entyvio · GATTEX · GIMOTI · HADLIMA · HUMIRA · Humira · IBSRELA · IDACIO · IQIRVO · LINZESS · Linzess · MAVYRET · MOTEGRITY · Mulpleta · OCALIVA · OMVOH · PLENVU · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUTAB · Sucraid · TREMFYA · TRULANCE · VEGZELMA · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for gastroenterology in OH.

Looking for a gastroenterology specialist in Fairfield?
Compare gastroenterologists in the Fairfield area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
126
Per 100K population
32.3
County median income
$81,194
Nearest hospital
MERCY HEALTH - FAIRFIELD HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wenzke is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 3% of OH peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wenzke experienced with colon polyp removal with endoscopic snare?
Based on Medicare claims data, Dr. Wenzke performed 121 colon polyp removal with endoscopic snare services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wenzke receive payments from pharmaceutical companies?
Yes. Dr. Wenzke received a total of $161,300 from 37 companies across 659 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wenzke's costs compare to other gastroenterologists in Fairfield?
Dr. Wenzke's average Medicare payment per service is $116. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wenzke) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →